ERBB2 and breast carcinoma: As biomarker status determination is one of the key elements of breast cancer diagnosis, carrying implications for treatment options, several studies have also explored the use of AI in the quantitative measurement of immunohistochemical stained estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor (HER2) and Ki67 images.